CLASS II Device recall · Reported 8 Sep 2021 · FDA Enforcement Report

Gyrus Acmi PKS Omni/-intended recalled by Olympus Corporation of the

Olympus Corporation of the Americas is recalling Gyrus Acmi PKS Omni/-intended for the electrosurgical coagulation, mechanical grasping, distributed nationwide in the US. The recall was initiated on 9 Jun 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot number KR121617
Quantity recalled6 boxes (5 per/box)=30 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2380-2021
FDA event ID
88448
Recalling firm
Olympus Corporation of the Americas, Center Valley, PA
Classification
Class II
Status
Terminated
Recall initiated
9 Jun 2021
FDA classified
27 Aug 2021
Reported
8 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Jun 2021Recall initiated by company
27 Aug 2021Classified by FDA+79 days
8 Sep 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Expired adhesive used as an electrical insulation barrier and as a secondary retention bond failed and could result in foreign body / biologic reaction within the patient and / or electrical continuity to patient causing tissue burn to critical structures.

Product as listed by the FDA

Gyrus Acmi PKS Omni 5mm/33cm-intended for the electrosurgical coagulation, mechanical grasping, and dissection of tissue during the performance of laparoscopic and general open surgical procedures when used in conjunction with the Gyrus ACMI G400 workstation Ref: 970010PC

Where it was distributed

US Nationwide distribution in the states of CA, GA, MN, TN.

Nationwide CaliforniaGeorgiaMinnesotaTennessee

Questions about this recall

Why was it recalled?

Expired adhesive used as an electrical insulation barrier and as a secondary retention bond failed and could result in foreign body / biologic reaction within the patient and / or electrical continuity to patient causing tissue burn to critical structures.

Which lots are affected?

Lot number KR121617

Where was it sold?

US Nationwide distribution in the states of CA, GA, MN, TN.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Olympus Corporation of the Americas

All 415

Other Surgical Instruments recalls

All 3,809